SCHEMBL9908126

SCHEMBL9908126

Cc1nc(-c2ccc3c(c2)OCO3)nc(C(Cl)(Cl)Cl)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
KDM4E B2RXH2 3/20 0.48
POLB P06746 1/20 0.48
GAA P10253 1/20 0.45
HSD17B10 Q99714 5/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
CLK4 Q9HAZ1 5/20 0.44
USP2 O75604 4/20 0.44
CYP1A2 P05177 4/20 0.44
CYP3A4 P08684 4/20 0.44
CYP2D6 P10635 4/20 0.44
CYP2C19 P33261 4/20 0.44
ADORA2A P29274 4/20 0.44
ADORA1 P30542 4/20 0.44
ALOX15 P16050 3/20 0.44
ADORA3 P0DMS8 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
LMNA P02545 2/20 0.44
TSHR P16473 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29352001 0.90 ADORA2A (0.47) ALDH1A1KDM4EPOLBGAAHSD17B10
SCHEMBL391704 0.90 ADORA2A (0.47) ALDH1A1KDM4EPOLBGAAHSD17B10
SCHEMBL12864670 0.85 ALDH1A1 (0.58) ALDH1A1KDM4EPOLBGAAHSD17B10
SCHEMBL5187633 0.79 SMN1; SMN2 (0.47) ALDH1A1KDM4EPOLBHSD17B10SMN1; SMN2
SCHEMBL14622040 0.78 MEN1 (0.40) ALDH1A1KDM4EPOLBGAAHSD17B10
SCHEMBL21933178 0.75 ADORA2A (0.36) ALDH1A1KDM4EPOLBGAAHSD17B10
SCHEMBL17447741 0.73 MAPT (0.42) ALDH1A1POLBGAAHSD17B10CLK4
SCHEMBL17447740 0.73 MAPT (0.42) ALDH1A1POLBGAAHSD17B10CLK4
SCHEMBL25440335 0.72 KDM4E (0.55) ALDH1A1KDM4EPOLBGAAHSD17B10
SCHEMBL10498406 0.72 ADORA2A (0.50) ALDH1A1KDM4EPOLBGAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8932398-B2 Gallotannic compounds for lithographic printing plate coating compositions MYLAN GROUP (VN) 2015-01-13 US disclosed
US-20120137929-A1 GALLOTANNIC COMPOUNDS FOR LITHOGRAPHIC PRINTING PLATE COATING COMPOSITIONS MYLAN GROUP (VN) 2012-06-07 US disclosed
US-8057986-B2 Method for forming resist pattern and method for manufacturing a semiconductor device FUJITSU LIMITED (JP) 2011-11-15 US disclosed
US-7776504-B2 Dye-containing resist composition and color filter using same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-08-17 US disclosed
US-7749664-B2 Dye-containing resist composition and color filter using same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-07-06 US disclosed
US-7465527-B2 Resist material, resist pattern and forming method for the same, and a semiconductor device and manufacturing method for the same FUJITSU LIMITED (JP) 2008-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120137929-A1 GALLOTANNIC COMPOUNDS FOR LITHOGRAPHIC PRINTING PLATE COATING COMPOSITIONS LGMN, GLMN, BMP4 ALDH1A1 3823/4885KDM4E 2456/4885POLB 3756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.